Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecific Antibody Targeting EGFR and LGR5, in Advanced HNSCC
Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecifi…
May 22, 2023
vumedi.com
Petosemtamab: um novo anticorpo contra o câncer
Petosemtamab: um novo anticorpo contra o câncer
3 days ago
terra.com.br
Merus présente des données intermédiaires sur le pétosemtamab dans le cancer colorectal métastatique
Merus présente des données intermédiaires sur le pétosemtam…
6 months ago
zonebourse.com
Everett E. Vokes, MD, FASCO, from UChicago Medicine presents interim results from a phase 3 trial comparing petosemtamab plus pembrolizumab versus pembrolizumab monotherapy for first-line treatment of recurrent/metastatic PD-L1-positive head and neck squamous cell carcinoma. Watch more here: https://www.onclive.com/view/petosemtamab-plus-pembrolizumab-vs-pembrolizumab-alone-for-first-line-1l-treatment-of-recurrent-metastatic-r-m-pd-l1-positive-head-and-neck-squamous-cell-carcinoma-hnscc-a-random
1:42
Everett E. Vokes, MD, FASCO, from UChicago Medicine presents interi…
67 viewsJan 6, 2025
FacebookOncLive
Dr Siu on the Rationale for Combining Petosemtamab With Pembrolizumab in HNSCC | OncLive
Dr Siu on the Rationale for Combining Petosemtamab With P…
Oct 4, 2024
onclive.com
Merus N.V.: Merus announces First Patient Dosed in Phase 2 Trial of Petosemtamab in 3L+ mCRC
Merus N.V.: Merus announces First Patient Dosed in Phase 2 Trial of P…
Dec 16, 2024
finanznachrichten.de
Dr Perez on the Efficacy and Safety of Frontline Petosemtamab Plus Pembrolizumab in HNSCC | OncLive
2:09
Dr Perez on the Efficacy and Safety of Frontline Petosemtamab Plus P…
Aug 8, 2024
onclive.com
0:37
Tune in to watch Lillian L. Siu, MD, FRCPC, discuss the background f…
42 viewsOct 10, 2024
FacebookOncLive
Merus' presents interim data on petosemtamab in metastatic color…
6 months ago
marketscreener.com
8:21
Petosemtamab (MCLA-158) With Pembrolizumab as First-line (1L) T…
Jun 16, 2024
onclive.com
Dr Fayette on the Efficacy of Petosemtamab Plus Pembrolizum…
Jul 15, 2024
onclive.com
Petosemtamab (MCLA-158) With Pembrolizumab as First-Line (1L) …
10 months ago
onclive.com
Petosemtamab Plus Pembrolizumab vs. Pembrolizumab Alone for Firs…
Sep 27, 2024
onclive.com
3:00
Current and upcoming clinical biomarkers for head and neck can…
21 views2 weeks ago
YouTubeVJOncology
53:12
Immune Innovation in Head and Neck Cancer
60 views2 months ago
YouTubePeerView Oncology
0:05
Newsmax Balkans Albania | Biologu Eduard Batlle, i rritur në pastiçerin…
56.1K views4 months ago
Instagramnewsmaxbalkans_albania
2:01
Petosemtamab has promising activity in advanced HNSCC
738 viewsApr 28, 2023
YouTubeVJOncology
5:21
Overcoming PD-1-resistance in head and neck cancer with ADCs and b…
47 views4 months ago
YouTubeVJOncology
1:16:37
Building on the Immunotherapy Foundation for Head and Neck Ca…
2.6K viewsJul 5, 2023
YouTubePeerView Oncology
14:09
#pertuzumab | Uses, Dosage, Side Effects & Mechanism | Perjeta
1.9K viewsOct 26, 2023
YouTubeHe-InFo
14:20
Key insights from head and neck research at ASCO 2025
224 views8 months ago
YouTubeecancer
Merus et Halozyme concluent un accord mondial de collaboration e…
5 months ago
zonebourse.com
6:33
Challenges & emerging therapies in HPV-independent head & neck ca…
26 views2 weeks ago
YouTubeVJOncology
Merus N.V. and Halozyme Therapeutics, Inc. Enter Global Co…
5 months ago
marketscreener.com
3:15
Phase II study of petosemtamab and pembrolizumab for recurrent/meta…
331 viewsJul 12, 2024
YouTubeVJOncology
5:19
PectaSol | Binding Supplement for Reducing Inflammation and Broa…
2K viewsFeb 19, 2024
YouTubegerstenberg.clinic
4:02
Peptamen Mechanisms of Action
19.9K viewsMar 30, 2016
YouTubeNestlé Health Science Canada
1:20
Comparing petosemtamab and pembrolizumab in HNSCC with exi…
216 viewsJul 12, 2024
YouTubeVJOncology
0:52
Hypertumours!!! Peto's paradox part 2 has arrived and this time we tal…
149.6K viewsMay 26, 2022
TikTokprimatepost
1:21
Important Peptide Announcement
4.5K views4 months ago
TikTokpeptisam_
See more videos
Static thumbnail place holder